Breathe Well Live Well
|
Survey finds one-third of patients with other respiratory conditions may have …
Healio “Asthma under/misdiagnosis and consequent inappropriate pharmacological treatment still affects asthma management. Furthermore they represent important factors contributing to asthma morbidity and mortality, whereas early detection and management … |
View full post on asthma – Google News
|
One-Third of Greenpoint's Vulnerable Population Report Asthma in Households
DNAinfo “The study confirms what North Brooklyn residents have known for ages: That asthma rates in North Brooklyn are alarmingly high, largely because of our neighborhood's disproportionate concentration of waste transfer stations and the consequent truck … |
View full post on asthma – Google News
|
Less than One-Third of Patients Taking Montelukast (Singulair®) Therapy for …
PR Newswire (press release) Montelukast is FDA-approved for treatment of asthma and allergic rhinitis. It works by inhibiting leukotrienes, the chemicals that cause inflammation. Montelukast is considered a second line of defense against asthma or allergic rhinitis. … |
View full post on asthma – Google News
|
Less than One-Third of Patients Taking Montelukast (Singulair®) Therapy for …
SYS-CON Media (press release) Montelukast is FDA-approved for treatment of asthma and allergic rhinitis. It works by inhibiting leukotrienes, the chemicals that cause inflammation. Montelukast is considered a second line of defense against asthma or allergic rhinitis. … |
View full post on asthma – Google News